+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cox Inhibitor"

Cyclo-oxygenase 2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Cyclo-oxygenase 2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 90 Pages
  • Global
From
Non Selective COX Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Non Selective COX Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Postoperative Pain - Epidemiology Forecast - 2032 - Product Thumbnail Image

Postoperative Pain - Epidemiology Forecast - 2032

  • Drug Pipelines
  • March 2022
  • 162 Pages
  • Global
From
From
Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

  • Report
  • November 2021
  • 600 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

The Cox Inhibitor market is a subset of the Analgesics market, which is composed of drugs used to relieve pain. Cox Inhibitors are a type of non-steroidal anti-inflammatory drug (NSAID) that work by blocking the enzyme cyclooxygenase (COX), which is responsible for the production of prostaglandins. Prostaglandins are hormones that cause inflammation and pain. By blocking the production of prostaglandins, Cox Inhibitors reduce inflammation and pain. Cox Inhibitors are used to treat a variety of conditions, including arthritis, headaches, muscle pain, and menstrual cramps. They are available in both over-the-counter and prescription forms. Common over-the-counter Cox Inhibitors include ibuprofen, naproxen, and aspirin. Prescription Cox Inhibitors include celecoxib, etoricoxib, and meloxicam. Some companies in the Cox Inhibitor market include Pfizer, Merck, Novartis, and Bayer. Show Less Read more